healthday7h
FDA Approves Susvimo for Diabetic Macular Edema
Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...
Cure Today10h
FDA-Approved Calquence Combo Is First and Only of Its Kind in MCL
Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...
healthday7h
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...
Medscape20h
Warning of Confusion Between Nasal and IV Epinephrine
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...
Interesting Engineering on MSN6h
Breakthrough: US FDA clears first gene-edited pig kidney transplants in humans
In a significant development for organ transplantation, two U.S. biotechnology companies, United Therapeutics and ...
Hosted on MSN16h
FDA approves the use of “audio glasses” for patients with hearing impairment
An 'audio glasses' device developed by EssilorLuxottica received approval from the U.S. Food and Drug Administration (FDA) ...
sinchew41m
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.
Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its independently developed ...
The Highland County Press11h
FDA approves novel non-opioid treatment for moderate to severe acute pain
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...
Prescriptions for weight loss drugs are skyrocketing, especially among young women. Experts think they know why.
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Pricing Headwinds Persist but Healthy Volume Trend and Systems Growth Offer Long-Term Upside
Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...
GEN8h
Recursion Announces Promising Clinical Data on Lead AI-Based Drug Candidate for Brain Disease
Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.
New York Post on MSN12h
Youth chasers are injecting trout and salmon sperm in faces instead of traditional fillers: ‘Results have been dramatic’
There’s nothing fishy about this skincare secret — unless you count the ingredients. The pursuit of plastic-free perfection ...